Very little is known about the spatiotemporal generation of lipid droplets (LDs) from the endoplasmic reticulum (ER) and the factors that mediate ER-LD contacts for LD growth. Using super-resolution grazing incidence structured illumination microscopy (GI-SIM) live-cell imaging, we reveal that upon LD induction, the ER-localized protein DFCP1 redistributes to nascent puncta on the ER, whose formation depends on triglyceride synthesis. These structures move along the ER and fuse to form expanding LDs. Fusion and expansion of DFCP1-labeled nascent structures is controlled by BSCL2. BSCL2 depletion causes accumulation of nascent DFCP1 structures. DFCP1 overexpression increases LD size and enhances ER-LD contacts, while DFCP1 knockdown has the opposite effect. DFCP1 acts as a Rab18 effector for LD localization and interacts with the Rab18-ZW10 complex to mediate ER-LD contact formation. Our study reveals that fusion of DFCP1-labeled nascent structures contributes to initial LD growth and that the DFCP1-Rab18 complex is involved in tethering the ER-LD contact for LD expansion.
INTRODUCTION
The lipid droplet (LD) consists of neutral lipids (e.g., triglycerides and sterol esters) that are enwrapped by a phospholipid monolayer (Yang et al., 2012; Joshi et al., 2017; Walther et al., 2017) . The LD surface is decorated with proteins that regulate lipid storage, metabolism, and movement of droplets (Kory et al., 2016) . LDs originate from the endoplasmic reticulum (ER), and their formation involves discrete steps (Kassan et al., 2013; Wang et al., 2016) . Neutral lipids synthesized in the ER bilayer membrane accumulate to form lens-like structures (Choudhary et al., 2015; Walther et al., 2017; Qi et al., 2017) . The growing droplet progressively distends the ER membrane and eventually buds off into the cytoplasm to form a nascent LD (Choudhary et al., 2015; Walther et al., 2017; Qi et al., 2017) . The egress of neutral lipids from the bilayer membrane and LD budding is specified by the ER phospholipid composition and surface tension (Ben M'barek et al., 2017; Choudhary et al., 2018) . The ER transmembrane protein FIT2 (fat-storage-inducing transmembrane) facilitates the emergence of LDs from the ER, probably by regulating diacylglycerol (DAG) levels at the sites of LD biogenesis (Choudhary et al., 2015) . Very little is known about the dynamics of the initial stage of LD formation. For example, whether a nascent LD is generated from individual neutral lipid-containing LD precursors or involves fusion of LD precursors remains unknown.
Nascent LDs, which may be connected to the ER or separated completely from it, reengage with the ER for expansion. LDs form contacts with the ER, in which two membranes are closely apposed (typically within 30 nm) and/or are physically connected with the ER by narrow membrane stalks. At the contact sites and membrane extensions, neutral lipids synthesized in the ER are transported to LDs for growth (Walther et al., 2017; Joshi et al., 2017) . ER-resident biosynthetic enzymes for neutral lipids, such as GPAT4 and DGAT2, also transfer from the ER to the LD surface via membrane connections for local lipid synthesis . Lipolysis of LDs also induces ER-LD contacts for back transport of phospholipids and droplet proteins to the ER (Kory et al., 2016) . LD growth can also result from fusion of LDs, which rarely occurs under normal conditions. Fusion of LDs is facilitated by phosphatidylcholine (PC) deficiency, phosphatidic acid (PA) accumulation, or expression of the LD-localized protein Fsp27 (Fei et al., 2011; Krahmer et al., 2011; Gong et al., 2011) .
Membrane contact sites (MCSs) are established by proteinprotein and/or protein-phosphoinositide interactions between the two opposing membranes (Phillips and Voeltz, 2016) . Several factors have been identified that are involved in the formation and/or maintenance of ER-LD contact. The lipid synthesis enzymes FATP1 (acetyl coenzyme A [acyl-CoA] synthetase) and DGAT2 (diacylglycerol acyltransferase), which are located on the ER and the LD, respectively, have been shown to form a complex to tether the ER to LDs, thus coupling the synthesis and deposition of triglycerides (TGs) into LDs (Xu et al., 2012) . The GTP-bound form of Rab18 interacts with the NRZ tethering factors (NAG-RINT1-ZW10) and their associated ER-localized SNAREs (Use1, Syntaxin18, and BNIP1) to promote the formation of ER-LD contacts for LD growth in preadipocytes (Xu et al., 2018) . The formation of membrane bridges between LDs and the ER is promoted by the Arf1-coatomer protein (COP) I machinery, which removes phospholipids from the LD surface and in turn increases LD surface tension (Thiam et al., 2013; Wilfling et al., 2014) . The stability of ER-LD contact is modulated by the ER-localized transmembrane protein EPG-3 (also known as VMP1), which activates the calcium transporter SERCA (Zhao et al., 2017) . The ER-resident transmembrane protein BSCL2, encoded by human Berardinelli-Seip congenital lipodystrophy 2, forms discrete foci at ER-LD contacts and controls the growth of nascent LDs to large mature LDs (Wang et al., 2016; Salo et al., 2016) . BSCL2 depletion causes accumulation of a large number of nascent LDs (not labeled by lipid dyes), clusters of small LDs, and a few supersized LDs (Wang et al., 2016; Salo et al., 2016) . The supersized LDs result from aberrant targeting of lipid synthesis enzymes and/or LD coalescence due to changes in phospholipid composition (Wang et al., 2016; Salo et al., 2016; Wolinski et al., 2015) . In BSCL2-depleted cells, ER-LD contacts are heterogeneous and morphologically irregular (Salo et al., 2016) . How BSCL2 participates in the formation, function, and/ or stabilization of ER-LD contacts remains largely unknown.
The ER also plays a pivotal role in the formation of the doublemembrane autophagosome in higher eukaryotes (Zhao and Zhang, 2018) . Upon autophagy induction, the Atg14L-Vps34 phosphatidylinositol 3-phosphate (PI(3)P) kinase complex is targeted to the ER to synthesize PI(3)P (Itakura and Mizushima, 2010) . The PI(3)P-enriched ER subdomains, known as omegasomes, act as platforms for autophagosome formation (Axe et al., 2008) . The omegasome extensively contacts and also forms membrane extensions with the isolation membrane (IM; autophagosomal precursor) during its expansion into an autophagosome (Zhao and Zhang, 2018) . The FYVE-domain-containing ER-localized protein DFCP1 (also known as ZFYVE1) migrates to omegasomes upon autophagy induction, a process that depends on both the ER localization domain and the PI(3)Pbinding FYVE domain (Axe et al., 2008) . DFCP1 does not move to IMs, and it migrates back to the ER when the IM closes into the autophagosome (Axe et al., 2008) . Although DFCP1 labels omegasomes, its knockdown (KD) causes no evident autophagy defects (Axe et al., 2008) . DFCP1 is also identified as a component of the LD proteome (Bersuker et al., 2018) , but its function in LD metabolism remains unknown.
Using a newly developed super-resolution live-cell imaging technique, we demonstrated that upon LD induction, DFCP1 forms small puncta on the ER in a manner that depends on TG synthesis. These DFCP1-labeled nascent structures move along the ER and fuse to form an expanding LD, which further grows into a large LD. BSCL2 is required for fusion and growth of DFCP1-labeled nascent structures. DFCP1 KD reduces, while DFCP1 overexpression enhances, ER-LD contacts. DFCP1 acts as a Rab18 effector and interacts with the Rab18-ZW10 complex to mediate ER-LD contact. Our study reveals that initial LD growth involves fusion of nascent DFCP1-labeled structures, and LD expansion is modulated by the DFCP1-mediated ER-LD contact.
RESULTS

DFCP1
Relocates from the ER to LDs upon LD Induction Under normal conditions, GFP-DFCP1 colocalized with the ER markers RFP-Sec61b and DsRed-KDEL ( Figures 1A and S1A ) (Axe et al., 2008) . After 6-h oleic acid (OA) treatment, DFCP1 tightly enclosed LDs stained by LipidTOX, and the fluorescence intensity of GFP-DFCP1 on the ER was concomitantly decreased in COS7 and HeLa cells ( Figures 1B, S1B , and S1C). GFP-DFCP1 fluorescence was enriched at LD-LD contact sites compared to other regions of LDs (Figures 1B and S1B-S1E). DFCP1-RFP also colocalized with the LD markers ACSL3 and GPAT4 after 6-h OA treatment ( Figures 1C and S1F ). Biochemical fractionation assays revealed that endogenous DFCP1 protein was present in purified LDs ( Figure S1G ). Levels of DFCP1 mRNA and proteins did not change after OA treatment (Figures S1H and S1I). We reconstructed the LD surface in three dimensions (3D) from deconvoluted structured illumination microscopy (SIM) images of LDs labeled by DFCP1 and found that DFCP1 was on the LD surface and tightly enwrapped the lipids ( Figure 1D ; Video S1).
The localization of DFCP1 was further determined by immunoelectron microscopy (EM) analysis. Gold particles recognizing GFP-DFCP1 specifically localized on the phospholipid monolayer surrounding LDs but were barely detected on the ER membrane ( Figure 1E ). More gold particles accumulated at LD-LD contact sites ( Figure 1F ). We also visualized the localization of DFCP1 using the chimeric APEX2-DFCP1 protein. APEX2 is an engineered peroxidase that catalyzes the formation of a highly electron-dense substance in the presence of diaminobenzidine (DAB) and OsO 4 , thus facilitating the EM analysis of protein localization (Lam et al., 2015) . Dark APEX2-DFCP1 signals were detected at the surface of LDs and the signal was stronger at LD-LD contact sites (Figures S1J and S1K) . Taken together, these results show that DFCP1 redistributes from the ER to LDs after OA treatment.
We performed fluorescence recovery after photobleaching (FRAP) assays to examine the mobility of DFCP1 on LDs. After 6-h OA treatment, the GFP-DFCP1 fluorescence signal was bleached on a portion of the LD. We found that the GFP signal recovered within 2 s ( Figures 1G and 1H) . Recovery of the DFCP1 signal was also observed after bleaching of an entire LD (either a single LD or an LD within a cluster; Figures 1G and  1H ). Thus, DFCP1 on the LD is mobile and exchanges with the ER and/or cytosol pool of DFCP1.
LD Localization of DFCP1 Depends on the ER Targeting Domain and the FYVE Domain DFCP1 contains an ER targeting domain and also a phosphoinositide-binding FYVE domain ( Figure S2A ). We treated the membrane fraction of cellular extracts with high pH (pH 11.5) or high-salt (0.5 M NaCl) buffers and found that endogenous DFCP1 was present in the supernatant but absent in the pellet (membrane fraction), suggesting that DFCP1 is not an integral transmembrane ER protein ( Figure S2B ). The mutation GFP-DFCP1(W543A), which disrupts the ER localization of DFCP1 (Axe et al., 2008) , prevented DFCP1 from anchoring onto LDs ( Figure 1I ). ER(DFCP1)-GFP, containing only the ER targeting (E and F) Immuno-EM analysis reveals that after 6-h OA treatment, gold particles (white arrowheads), indicating GFP-DFCP1, localize on the LD surface (E) and are enriched at the contact sites (F). Scale bars, 200 nm (inserts, 100 nm). (G) After 6-h OA treatment in HeLa cells, the fluorescence signal of GFP-DFCP1 recovered after photobleaching. Arrowheads indicate the site where the GFP signal was photobleached. Scale bars, 1 mm.
(H) The graph shows the time-dependent recovery of GFP-DFCP1 fluorescence on LDs after photobleaching in HeLa cells treated with OA for 6 h (n = 6 LDs for each independent experiment). M t indicates the proportion of bleached protein that is replaced by unbleached protein during the recovery monitoring period; t 1/2 is the half-time of recovery, i.e., the time that the fluorescence reaches half of its maximal recovery intensity. Mean ± SEM is shown. (legend on next page) domain of DFCP1, labeled LDs after OA treatment, but the fluorescence signal on the LD was weaker than that of DFCP1 (Figure 1J ). Chimeric proteins containing the ER-targeting domain of DFCP1 and the FYVE domain derived from DFCP1 or FENS, ER+FYVE(DFCP1) and ER(DFCP1)+FYVE(FENS), exhibited a strong GFP signal on the LD, like full-length DFCP1 ( Figures 1K  and S2C ). Compared to DFCP1 and ER+FYVE(DFCP1), the half-time for recovery of the ER(DFCP1)-GFP fluorescence signal after photobleaching on LDs and the ER was shorter (Figures S2D-S2G) . Thus, the FYVE domain contributes to the retention of DFCP1 on LDs.
Upon autophagy induction, DFCP1 moves to omegasomes in a manner that depends on the binding of PI(3)P to the FYVE domain and is abolished by wortmannin treatment (Axe et al., 2008) . After OA treatment for 6 h, DFCP1 still colocalized with LC3 puncta upon starvation ( Figure S2H ). The LD localization of DFCP1, however, persisted after wortmannin treatment (Figure S2I) . Mutations in the FYVE domain residues that are critical for PI(3)P binding, C650S and C770S (Axe et al., 2008) , did not prevent DFCP1 from localizing to LDs ( Figure 1L ). Thus, PI(3)P is not required for the redistribution of DFCP1 from the ER to LDs. FYVE(FENS)-TM(CytoB5)-GFP, in which the bilayer-spanning ER domain from CytoB5 is linked to the FYVE domain of FENS, labels the omegasome (Axe et al., 2008) . However, it failed to be recruited to LDs ( Figure S2J ). These results indicate that the ER-targeting domain and FYVE domain mediate the LD localization of DFCP1.
DFCP1 Labels Nascent LD Structures on the ER that Move and Fuse to Form an Expanding LD at the Early Stages of LD Biogenesis We used grazing incidence structured illumination microscopy (GI-SIM) to examine the spatiotemporal recruitment of GFP-DFCP1 to LDs upon OA treatment. Compared to spinning-disk confocal microscopy or commercial SIM systems, GI-SIM provides a higher spatiotemporal resolution of 95 nm and 40 frames per second. Moreover, its axial illumination depth reaches $1 mm, enabling us to examine the dynamics of subcellular organelles (Nixon-Abell et al., 2016) . Formation of LDs at different stages can be monitored by different assays. LipidTOX stains LDs with a moderate amount of neutral lipid accumulation. HPos (containing the ER-anchoring hydrophobic domain of ALDI and the LD-targeting motif of caveolin-1) translocates from the ER to LDs before lipid accumulation can be stained by neutral lipid dyes (e.g., LipidTOX and BODIPY) (Kassan et al., 2013) and thus serves as a marker to detect the early stages of LD formation.
Time-lapse analysis using GI-SIM was performed to examine the temporal relationship of GFP-DFCP1 with mCherry-HPos. Before OA addition, GFP-DFCP1 colocalized with the ER marker RFP-Sec61b or mCherry-HPos on the ER ( Figures 1A and 2A ). After OA treatment for $5 min, GFP-DFCP1 started to form a few new puncta, which were negative for mCherry-HPos, on the ER ( Figure S3A ). The number of DFCP1 puncta continued to increase up until 15 min (Figures 2B and 2D) . A fraction of DFCP1 puncta became positive for mCherry-HPos (Figures 2B and 2D). After OA treatment for 20 min, only a few small DFCP1 puncta were present, but the GFP-DFCP1 + mCherryHPos + puncta gradually enlarged and became ring-like structures that continued to grow ( Figures 2C, 2D , S3B, and S3C). During LD formation, the GFP-DFCP1 signal intensity on the LD increased ( Figure S3D ). We further analyzed the dynamics of DFCP1 puncta. 64.1% of DFCP1 puncta dissipated into the ER (Figures 2E and 2H ; Video S2), indicating that punctum formation is reversible. 33.1% of the DFCP1 puncta rapidly moved along the ER and fused with each other and/or a DFCP1 punctum that was already positive for mCherry-HPos or LipidTOX, resulting in growth of the puncta (Figures 2F, 2H, and S3E; Video S2). 63.3% of GFP-DFCP1 + mCherry-HPos + puncta were formed at three-way junctions of ER tubules ( Figure 2G ). Some DFCP1 puncta also detached from, and then migrated back to, the ER ( Figure S3F ). 2.8% of DFCP1 puncta grew into LDs that were stained by LipidTOX (Figure 2H ). We also determined the dynamics of GFP-DFCP1, mCherry-HPos, and LipidTOX upon OA treatment. After OA treatment, GFP-DFCP1 puncta first emerged on the ER and then became mCherry-HPos positive. The puncta were then gradually stained by LipidTOX ( Figure 2G ). The DFCP1 puncta negative for LipidTOX staining are named hereafter as nascent DFCP1 puncta.
The resolution of GI-SIM could not differentiate between structures on the ER or adjacent (<100 nm) to the ER. We performed EM analysis to further characterize DFCP1 structures at early stages of LD biogenesis. After OA treatment for 15 min, in APEX2-DFCP1-expressing cells, DAB stained small papillary structures on the ER and also spherical structures (<100 nm) adjacent to the ER ( Figures 2I, 2J , and 2L). Formation of puncta positive for LiveDrop, a widely used nascent LD marker (Wang et al., 2016) , occurred later than DFCP1 (Figure S3G ). APEX2-LiveDrop labeled spherical structures (<100 nm) close to the ER but only a few papillary structures ( Figures 2K and 2L) .
To further determine whether DFCP1 puncta represent early LD structures, we treated cells with the TG synthesis inhibitor D1i, which inhibits DGAT1 activity. We found that formation of nascent DFCP1 puncta was almost abolished ( Figure 2M ). FIT2 regulates emergence of LDs from the ER. FIT2 KD causes a dramatic reduction in the number and size of LDs (Choudhary et al., 2015) . Knocking down FIT2 dramatically reduced the formation of nascent DFCP1 puncta ( Figures 2N and S3H ), suggesting that DFCP1-labeled structures are LD precursors. Taken together, these results indicate that DFCP1 is an earlier LD marker than mCherry-HPos and labels nascent LD structures, which fuse to form expanding LDs.
BSCL2 Controls Dissipation and Fusion of DFCP1-Labeled Nascent LDs BSCL2 acts at the ER-LD contact site to regulate LD biogenesis (Wang et al., 2016; Salo et al., 2016) . After 6-h OA treatment, BSCL2-GFP or endogenous BSCL2 formed distinct puncta that associate with LDs in control cells (Wang et al., 2016; Salo et al., 2016) (Figures S4A and S4C ). In cells expressing mCherry-DFCP1, BSCL2-GFP, or endogenous BSCL2 closely encircled DFCP1-labeled LDs ( Figures S4B and S4D ). We knocked down BSCL2 by RNAi in COS7 and HeLa cells to examine whether BSCL2 regulates the dynamics of DFCP1 puncta during LD formation ( Figures S4E-S4G ). After 6-h OA treatment, the number of GFP-DFCP1 puncta was much greater, while the localization of DFCP1 on LipidTOX-stained LDs was weaker, in BSCL2 KD cells than in negative control (NC) cells ( Figures 3A, 3B , S4H, and S4I). BSCL2 depletion also suppressed the LD localization of ER(DFCP1)-GFP ( Figures S4J  and S4K ). These results indicate that BSCL2 regulates DFCP1 targeting to mature LDs.
We next performed time-lapse analysis using GI-SIM to determine the spatiotemporal formation of DFCP1 puncta in BSCL2 KD cells. Before addition of OA, ER localization of DFCP1 was weaker in BSCL2 KD cells than in NC cells ( Figures  3C and S4L ), suggesting that BSCL2 regulates the ER association of DFCP1. After OA treatment, nascent DFCP1 puncta emerged from the ER in BSCL2 KD cells ( Figures 3D-3F Figures 3D-3F and 3H ). GFP-DFCP1 + mCherry-HPos À puncta were able to move to the ER three-way junctions in BSCL2 KD cells and become GFP-DFCP1 + mCherry-HPos + puncta ( Figure 3G ; Video S3). However, they were not stably anchored at the three-way junction. The GFP-DFCP1 + mCherry-HPos À puncta migrated away (Figure 3G; Video S3) . In BSCL2 KD cells, GFP-DFCP1 + mCherryHPos + puncta sometimes formed clusters at the ER threeway junction, but the clusters were irregularly shaped and failed to grow in size ( Figure S4M ; Video S3). The dissipation of GFP-DFCP1 + mCherry-HPos À puncta into the ER was also inhibited in BSCL2 KD cells ( Figure 3I ; Video S3). Therefore, a large number of nascent GFP-DFCP1 puncta persisted even after 20-min OA treatment in BSCL2 KD cells ( Figures 3F and 3H ). BSCL2 KD cells also contained a few GFP-DFCP1 + mCherry-HPos + ring structures, with which nascent DFCP1 puncta could fuse (Figure S4N ). The growth of these LD structures was faster than in control cells ( Figure S4O ). However, the increase in DFCP1 fluorescence intensity on LDs was less in BSCL2 KD cells (Figures S4O and S4P) . Depletion of BSCL2 resulted in accumulation of nascent LDs, which were not stained by LipidTOX (Wang et al., 2016) . BSCL2 KD cells contain both small and supersized LipidTOX-positive LDs (Wang et al., 2016; Salo et al., 2016) (Figures S4Q and S4R) . EM analysis showed that APEX2-DFCP1 strongly labeled nascent LDs (<100 nm), but not small and supersized LDs ($300 nm and $1 mm, respectively) in BSCL2 KD cells ( Figure 3J ). Therefore, BSCL2 is required for the maturation of DFCP1-labeled nascent LDs into LipidTOX-positive mature LDs.
DFCP1 Regulates the Size of LDs
We next investigated the role of DFCP1 in LD biogenesis. DFCP1 was knocked down by small interfering RNA (siRNA) in COS7 and HeLa cells ( Figures S5A and S5B ). After 6-h OA treatment, the average size of LDs was 0.78 mm in control COS7 cells and 1.45 mm in control HeLa cells, which was reduced to 0.65 mm and 1.18 mm in DFCP1 KD cells, respectively ( Figures 4A-4C and S5C-S5E). The number of LDs increased in DFCP1 KD cells ( Figures 4D and S5F ). Compared to control mouse embryonic fibroblasts (MEFs), LDs were also smaller and more abundant in DFCP1 KO MEFs ( Figures S5A and S5G-S5J ). In contrast to DFCP1 KD, overexpression of GFP-DFCP1 increased the size of LDs (Figures 4E-4G ). LDs also formed clusters in DFCP1-overexpressing cells ( Figure 4F ). Overexpression of ER(DFCP1) and ER+FYVE(DFCP1) also increased LD size ( Figures 4G,  S5K , and S5L). These results indicate that DFCP1 regulates the size and distribution of LDs.
DFCP1 Modulates the Formation of ER Contacts with LDs
After OA treatment for 6 h, the ER marker GFP-Sec61b was separable from LDs in control cells ( Figure S5M ) while they closely enveloped the LDs in DFCP1-overexpressing cells (Figure S5N ). This suggests that the ER is closely associated with LDs. The mobility of LDs is affected by their association with the ER (Salo et al., 2016) . We measured LD mobility after 1-h OA treatment and found that it was increased from 0.060 mm/s in control cells to 0.106 mm/s in DFCP1 KD cells and reduced to 0.051 mm/s in DFCP1-overexpressing cells ( Figures S5O-S5R ). We also purified LDs to assess the association of ER with LDs. The ER-localized protein Sec61b dramatically accumulated in LDs purified from DFCP1-overexpressing cells compared to control cells ( Figure 4H ). EM analysis was performed to directly visualize the contact between the ER and LDs. Compared to control cells, the percentage of LDs in contact with the ER, as well as their average perimeter, was decreased in DFCP1 KD cells ( Figures 4I-4L) , while ER-LD contact was dramatically elevated in cells 
(legend continued on next page)
overexpressing ER(DFCP1) or DFCP1 ( Figures 4M-4Q ). ER-LD contact was also decreased in DFCP1 KD and increased in DFCP1-overexpressing HeLa cells ( Figures S5S-S5W ). Thus, DFCP1 promotes the formation of ER-LD contacts. We next examined the formation of the FATP1-DGAT2 complex, which has been shown to tether the ER to LD contacts for LD expansion (Xu et al., 2012) . Levels of FATP1 co-immunoprecipitated by DGAT2 were higher in DFCP1-overexpressing cells and lower in DFCP1 KD cells ( Figures 4R and 4S) , supporting a role of DFCP1 in mediating ER-LD contact.
Rab18 Is Required for LD Targeting of DFCP1 and for the Role of DFCP1 in Mediating ER-LD Contact
Previous studies showed that upon LD induction, Rab18 localizes to LDs and induces close apposition of LDs with the ER (Ozeki et al., 2005) . The LD localization of Rab18 depends on its activation (Ozeki et al., 2005) . A GTPase-defective mutant (Q67L) of Rab18, but not a GDP-bound mutant (S22N), showed LD localization in COS7 cells ( Figures S6A and S6B ). DFCP1-RFP colocalized with GFP-Rab18(Q67L) on LDs after 6-h OA treatment ( Figure S6C ). Rab18 binds to the NAG-RINT-ZW10 (NRZ) tethering complex to modulate ER-LD contact in preadipocytes (Xu et al., 2018) . mCherry-DFCP1 colocalized with GFP-Rab18 and 3 3 Myc-ZW10 on LDs after 6-h OA treatment ( Figure S6D ). Knocking down Rab18 and ZW10 causes the formation of supersized LDs in 3T3-L1 preadipocytes ( Figures  S6E-S6I) (Xu et al., 2018) . However, in Rab18 or ZW10 KD COS7 cells, the LDs were smaller and more abundant, similar to DFCP1 KD COS7 cells (Figures S6J-S6Q ). DFCP1 KD caused the formation of supersized LDs in 3T3-L1 cells ( Figures S6R and  S6S ). These results indicate that Rab18, ZW10, and DFCP1 play a similar role in LD biogenesis and that inactivation of these components causes different phenotypes in different cell types.
We used GI-SIM to examine whether Rab18 labels nascent LD structures. Rab18(Q67L), which exhibits strong LD localization, was used to facilitate the analysis. GFP-Rab18(Q67L) was distributed throughout the ER before OA addition ( Figure 5A ). After OA treatment, GFP-Rab18(Q67L) condensed at discrete sites on the ER that colocalized with mCherry-DFCP1 puncta and ring structures (Figures 5B and 5C ; Video S4). GFP-Rab18(Q67L)-positive sites and mCherry-DFCP1 puncta emerged from the ER at the same time, and the two markers moved together ( Figure 5D ; Video S4), indicating that Rab18 is also targeted to nascent LDs. In BSCL2 KD COS7 cells, Rab18 formed numerous puncta that failed to be stained by LipidTOX (Figures 5E and 5F ). GI-SIM analysis revealed that Rab18 formed punctate structures that colocalized with nascent DFCP1 puncta in BSCL2 KD cells after OA treatment (Figures S6T and S6U ; Video S5).
We next examined whether Rab18 regulates the LD localization of DFCP1 upon LD induction. In Rab18 KD cells, GFP-DFCP1 failed to enclose LDs after 6-h OA treatment ( Figure 5G ). GI-SIM showed that formation of nascent DFCP1 puncta was also suppressed in Rab18 KD cells after OA treatment (Figure S7A) . Consistent with this, EM analysis revealed that LDs in Rab18 KD cells were not labeled by APEX2-DFCP1 ( Figures  S7B and S7C ). Rab18 depletion also suppressed the ER-LD contacts induced by DFCP1 overexpression. The percentage of LDs, as well as the average perimeter, in contact with the ER in cells overexpressing GFP-DFCP1 was decreased by simultaneous depletion of Rab18 (Figures 5H-5K ). ZW10 KD did not affect the LD localization of DFCP1 ( Figure S7D ). These results indicate that Rab18 is required for the LD localization of DFCP1 and for its function in tethering the ER to LDs.
GFP-Rab18 was still targeted to LDs in DFCP1 KD cells (Figure S7E ), but at a reduced level. The percentage of LDs and the average perimeter in contact with the ER in cells overexpressing Rab18, however, were decreased by DFCP1 KD (Figures 5L-5P) . Therefore, DFCP1 is also required for Rab18-mediated ER-LD contact.
DFCP1 Forms a Complex with Rab18-ZW10
We determined whether DFCP1 is directly recruited to LDs by Rab18. GFP-DFCP1 precipitated endogenous Rab18 in coimmunoprecipitation (coIP) assays ( Figure 6A ). Levels of precipitated Rab18 were slightly increased after OA treatment (Figure 6A) . Endogenous DFCP1 was also co-immunoprecipitated by endogenous Rab18 ( Figure 6B ). Compared to wild-type Rab18, the levels of DFCP1 co-precipitated by Rab18(Q67L) and Rab18(S22N) were more and less, respectively, after 6-h OA treatment ( Figure 6C ). In vitro pull-down assays showed that DFCP1 directly bound to Rab18 and Rab18(Q67L), but not to GST-Rab18(S22N) (Figures 6D and S7F ). The N terminus and also the ER localization domain of DFCP1 exhibited Rab18-binding activity in in vitro GST pull-down assays (H) GFP-DFCP1 is enriched in the LD fraction. Levels of the ER membrane (detected by Sec61b) cofractionated with LDs is increased in GFP-DFCP1 overexpression cells. PNS, post-nuclear supernatant; TM, total membrane; Cyto, cytosol; LD, lipid droplets. ADRP, LD marker; Sec61b, ER marker. ( Figure S7G ). These results suggest that DFCP1 acts as a Rab18 effector.
Endogenous ZW10 was also co-immunoprecipitated by GFP-DFCP1, and levels of precipitated ZW10 were increased after OA treatment ( Figure 6A ). The interaction between Rab18 and ZW10 was reduced in DFCP1 KD cells ( Figure 6E ). Knocking down Rab18 and ZW10 had no obvious effect on the DFCP1-ZW10 interaction and the DFCP1-Rab18 interaction, respectively (Figures 6F and S7H) . Depletion of one component of the Rab18-DFCP1-ZW10 complex reduced the levels of the other proteins ( Figure 6G ). The ER-localized transmembrane protein EPG-3 (VMP1) modulates the stability of ER-LD contacts (Zhao et al., 2017) . In VMP1 KO cells, the ER-LD contacts are dramatically increased (Zhao et al., 2017) . We found that compared to control cells, interactions of DFCP1 with Rab18 and ZW10 were increased in VMP1 KO cells ( Figure 6H ). Therefore, DFCP1 forms a complex with Rab18-ZW10 and modulates the assembly and/ or stability of the complex.
BSCL2 Modulates ER-LD Contact
Mediated by the DFCP1-Rab18-ZW10 Complex BSCL2 has been shown to modulate the formation, stabilization, and function of ER-LD contacts (Salo et al., 2016) . We determined whether BSCL2 regulates ER-LD contacts mediated by the Rab18-DFCP1 complex. Simultaneous depletion of BSCL2 resulted in the formation of both small and supersized LDs in (legend continued on next page) DFCP1-or Rab18-depleted or overexpressing cells (Figures S7I  and S7J ; data not shown). Consistent with previous studies (Salo et al., 2016) , association of the ER with the LD surface was increased on average in BSCL2 KD cells compared to control cells ( Figures 7A, 7B, 7E, and 7F) . Enhanced ER-LD contact in DFCP1-overexpressing cells was suppressed by simultaneous depletion of BSCL2, so that the extent of ER-LD contact resembled that in BSCL2 single KD cells (Figures 7C-7F) .
We examined whether BSCL2 interacts with the DFCP1-Rab18 complex. In coIP assays, endogenous Rab18 precipitated endogenous BSCL2 ( Figure 6B ). BSCL2 was also coimmunoprecipitated by DFCP1 ( Figure 6F ). The ER domain of DFCP1 precipitated BSCL2 in coIP assays ( Figure S7K ). The interaction between DFCP1 and BSCL2 was not affected by OA treatment ( Figure S7L ) but was greatly suppressed in Rab18 KD cells ( Figure 6F ), suggesting that Rab18 facilitates the interaction between BSCL2 and DFCP1. The interaction of Rab18 with BSCL2 was not reduced in ZW10 KD cells (Figure S7H) . Levels of endogenous Rab18 and ZW10 co-precipitated by DFCP1 were not evidently affected by BSCL2 depletion ( Figure S7M ). These results suggested that BSCL2 interacts with the Rab18-DFCP1-ZW10 complex to modulate ER-LD contact formation. Depletion of Rab18 or DFCP1 also suppressed the increased ER-LD contact in BSCL2 KD cells ( Figures 7G-7N) , indicating that the DFCP1-Rab18 complex also modulates ER-LD contact independent of BSCL2.
DISCUSSION
Fusion of DFCP1-Labeled Nascent LD Structures at the Early Stages of LD Biogenesis LDs are generated from the ER (Walther et al., 2017; Qi et al., 2017) . Neutral lipids synthesized in the ER membrane bilayer accumulate into lens-like structures, which further grow and bud into the cytoplasm. These newly budded nascent LDs do not contain enough lipids to be detected by neutral lipid dyes (e.g., BODIPY and LipidTOX) but can be labeled by HPos and LiveDrop (Kassan et al., 2013; Wang et al., 2016) . The nascent LDs reassociate with the ER to acquire more lipids and/or TG synthesis enzymes (e.g., GPAT4 and DGAT2) to generate TG for LD growth (Wang et al., 2016; Salo et al., 2016) .
Using super-resolution GI-SIM, which has a much higher speed and greater imaging depth than confocal microscopy (Nixon-Abell et al., 2016), we visualized the dynamics of early steps involved in LD formation. Upon LD induction, small DFCP1 puncta emerge from the ER, and the formation of these puncta depends on TG synthesis. DFCP1 puncta appear earlier and are more abundant than puncta labeled by HPos and LiveDrop. Formation of DFCP1-labeled nascent structures is reversible, and the majority of them dissipate into the ER. The DFCP1-labeled puncta move along the ER, fuse with each other, and mature into more advanced LD structures that are positive for both HPos and DFCP1. The double-positive puncta are mainly located at ER three-way junctions and further grow into mature LDs ( Figure 7O) . Thus, formation of DFCP1-positive nascent structures constitutes an early step of LD formation. How DFCP1 concentrates at discrete sites upon LD induction remains unresolved, as does the nature of DFCP1 puncta. Nascent DFCP1 structures may be enriched in TGs. Alternatively, DFCP1 may accumulate at ER sites with a membrane change associated with LD formation.
In BSCL2 KD cells, the dissipation of DFCP1 puncta into the ER and fusion of nascent LDs and their maturation into expanding LDs at three-way junctions is greatly inhibited. The mechanism by which BSCL2 controls the dynamics of DFCP1 puncta at early stages of LD biogenesis has yet to be determined. BSCL2 could mediate the reengagement of nascent LDs with the ER and/or stabilize them on the ER by interacting with the DFCP1-Rab18 complex and other unidentified factors. Another possibility is that BSCL2 may modulate the lipid and protein composition of nascent DFCP1 structures to specify their fusion capability.
DFCP1 Forms a Complex with Rab18-ZW10 to Mediate ER-LD Contact
Targeting DFCP1 to nascent and mature LDs requires Rab18. DFCP1 acts as a Rab18 effector. DFCP1 binds strongly to active mutant Rab18(Q67L), but not to GDP-bound mutant Rab18(S22N). Rab18 directly interacts with ZW10, which further interacts with ER-localized SNAREs to establish ER-LD contact (Xu et al., 2018) . DFCP1 mediates the ER-LD contact by forming a complex with Rab18 and ZW10. The number of LDs and also the average length of the LD perimeter in contact with the ER is increased by overexpression of DFCP1 and reduced by depletion of DFCP1. The enhanced ER-LD contact caused by DFCP1 overexpression depends on Rab18, and the enhanced ER-LD contact induced by Rab18 overexpression requires DFCP1. In VMP1/EPG-3-depleted cells, in which ER-LD contact is greatly enhanced (Zhao et al., 2017) , the formation of the DFCP1-Rab18-ZW10 complex is elevated. LD biogenesis is modulated by ER-LD contact. The LDs are smaller and more numerous in DFCP1 KD COS7 and HeLa cells and larger in cells overexpressing DFCP1. In Rab18 or ZW10 KD COS7 and HeLa cells, LDs are also smaller and greater in number. Formation of the FATP1-DGAT2 complex at ER-LD contact sites for TG synthesis is reduced by DFCP1 depletion and enhanced by DFCP1 (E) The interaction between Rab18 and ZW10 is reduced in DFCP1 KD cells. Levels of ZW10 co-precipitated by GFP-Rab18 (normalized by GFP-Rab18 levels) are quantified. (legend continued on next page) overexpression (Xu et al., 2012) . The DFCP1-Rab18-ZW10 complex may also interact with lipid transfer proteins or regulate other aspects of LDs such as lipid and protein composition to modulate LD biogenesis.
Two types of ER-LD contact have been reported that act differently in lipid and protein transfer. One type involves close apposition of the ER to LDs. Formation of these contacts is mediated by protein-protein and/or protein-phosphoinositide interactions (Phillips and Voeltz, 2016) . Another type of contact contains membrane extensions linking the ER to LDs. Neutral lipids generated in the ER and ER-localized TG synthesis enzymes are directly transferred via these extensions to LDs. LDs in different cell types have unique features such as lipid composition and LD proteins. For example, phospholipid metabolism may be distinct and the LD fusion-promoting protein Fsp27 may be differentially expressed in different cell types (Gong et al., 2011; Qi et al., 2017) . Formation of these two types of ER-LD contact may be differentially modulated by the DFCP1-Rab18-ZW10 complex in different cell types. In 3T3-L1 cells, depletion of components of the DFCP1-Rab18-ZW10 complex leads to formation of supersized LDs, which could be caused by the formation of membrane extensions between the ER and LDs (Wolinski et al., 2015) .
BSCL2 Regulates the Role of the DFCP1-Rab18-ZW10
Complex in ER-LD Contact Formation BSCL2 forms distinct puncta at ER-LD contact sites and modulates the formation, stabilization, and function of ER-LD contacts (Wang et al., 2016; Salo et al., 2016; Cartwright et al., 2015) . BSCL2 has been shown to facilitate the transport of proteins such as ACSL3 and HPos from the ER into expanding LDs and/or to prevent equilibration of ER and LD surface components (Wang et al., 2016; Salo et al., 2016) . We found that in the absence of BSCL2, trafficking of DFCP1 and Rab18 to nascent LD structures occurs, while their localization to mature LDs is greatly reduced, which may result from their impaired transfer from the ER to expanding LDs or retention at the LD monolayer. Depletion of BSCL2 suppresses the enhanced ER-LD contact in DFCP1-or Rab18-overexpressing cells. BSCL2 may directly participate in contact formation by interacting with the DFCP1-Rab18 complex. It is also possible that BSCL2 modulates the lipid and protein composition at the contact sites, which in turn facilitates the ER-LD contact mediated by the DFCP1-Rab18 complex. In BSCL2 KO cells, ER-LD contacts are heterogeneous and irregular. A fraction of LDs, including supersized LDs, exhibit extensive contact and membrane bridges with the ER (Salo et al., 2016) . The enhanced ER-LD contact in BSCL2 KD cells is suppressed by simultaneous depletion of Rab18 or DFCP1. Thus, the DFCP1-Rab18 complex has a BSCL2-independent function in tethering the ER with LDs.
The LD defect in DFCP1-and Rab18-depleted COS7 and HeLa cells is not identical to that in BSCL2 KD cells. DFCP1 KD and Rab18 KD cells contain uniformly small LDs that are stained by lipid dyes. The LDs in BSCL2 KD cells are heterogeneous in size and include the supersized LDs that may result from premature targeting of lipid synthesis enzymes and/or LD coalescence due to changes in phospholipid composition (Wang et al., 2016; Salo et al., 2016; Wolinski et al., 2015) . BSCL2 appears to have other functions in the control of LD biogenesis in addition to mediating ER-LD membrane contact. Our study shows that the DFCP1-Rab18 complex is involved in modulating the formation and/or stability of ER-LD contacts to regulate LD biogenesis.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: BSCL2 KD, n = 155 LDs; DFCP1 KD, n = 102 LDs; Rab18 KD, n = 114 LDs; DFCP1 KD with simultaneous KD BSCL2, n = 129 LDs; Rab18 KD with simultaneous KD BSCL2, n = 132 LDs). Mean ± SEM is shown. ***p < 0.001; **p < 0.01; *p < 0.05 (O and P) Models for the initial stage of LD formation in control and BSCL2-deficient cells. Upon LD induction, DFCP1 associates with nascent LD structures in a manner that depends on TG synthesis. These nascent LDs move along the ER and fuse with each other at the ER three-way junction site to form expanding LDs. The nascent LDs may have detached from the ER or remain connected with the ER via thin membrane bridges. The nascent LDs can also dissipate into the ER. HPos mainly labels the expanding LD at ER three-way junction sites. BSCL2 modulates the dynamics and maturation of nascent LDs (stage one). As the expanding LDs grow in size, DFCP1 and Rab18 are also transported from the ER to the LD (stage two). The insert in (O) shows the formation of the DFCP1-Rab18-ZW10 complex at the ER-LD contact site. In BSCL2-deficient cells, dissipation of nascent DFCP1 puncta into the ER is inhibited. A few LDs engage with the ER for growth (P). See also Figure S7 . diluted with PBS, the nickel grids were probed with gold-conjugated particles in 1% BSA diluted with PBS for 2 hr at room temperature. The ultrathin sections were then stained and examined. Images were captured by a Gatan-832 digital camera on a 120 kV Jeol electron microscope (JEM-1400) at 80 kV.
FRAP experiment
LDs were stained with LipidTOX for 15 min and then fluorescence recovery after photobleaching (FRAP) experiments were performed on a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) using a 63 3 oil immersion objective lens (Plan-Apochromatlan, Zeiss) and a camera (Axiocam HRm, Zeiss) at room temperature. A defined region of interest was photobleached at full laser power at 488 nm (100% power, 20 iterations). Fluorescence intensity was normalized to the pre-bleach intensity. Image intensity was measured by Mean ROI on a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) and further analyzed by Prism (GraphPad).
Grazing incidence SIM
After seeding on 25-mm coverslips, COS7 cells were transfected with NC or siRNA oligos for 48 hr, and transfected with the indicated plasmids for the last 24 hr. Before imaging, COS7 cells were stained with LipidTOX for 15 min.
The grazing incidence structured illumination microscopy (GI-SIM) apparatus was built based on an inverted fluorescence microscope (IX83, Olympus, Japan). In this system, the light beams from a laser combiner equipped with 488 nm (500 mW, Coherent, Genesis Max 488-500 STM), and 560 nm (1W, MPB Communications, VFL-P-500-560) lasers are passed through an acousto-optic tunable filter (AOTF; AA Quanta Tech, AOTFnc-400.650-CPch-TN), which is used to dynamically select the excitation laser and control its power inputting into the backward light path. The output beam from the AOTF is then expanded to a 1/e diameter of 12 mm and sent to a phase-only modulator consisting of a polarizing beam splitter, an achromatic half-wave plate (HWP; Bolder Vision Optik, BVO AHWP3), and a ferroelectric spatial light modulator (SLM; Forth Dimension Displays, SXGA-3DM). The light diffracted by the grating pattern displayed on the SLM passes through a polarization rotator consisting of a liquid crystal cell (LC; Meadowlark, SWIFT) and an achromatic quarter wave plate (QWP; Bolder Vision Optik, BVOAQWP3), which rotates the linear polarization of the diffracted light so as to maintain the S-polarization necessary to maximize the pattern contrast for all pattern orientations.
Images were captured with an Olympus 1.7-NA objective under the physiological conditions of 37 C and 5% CO 2 . Three raw images were acquired at successive phase steps of 0, 1/3, and 2/3 for each illumination time-point. This process was repeated with the standing wave excitation pattern rotated ± 120 with respect to the first orientation, for a total of nine raw images. In this work, we used an imaging speed of 1 frame per 4, 5 or 10 s at 50 W/cm 2 excitation intensity, and continuously imaged $200 time-points.
QUANTIFICATION AND STATISTICAL ANALYSIS
Immunoblotting, in-vitro pulldown and Co-IP results are representative of three independent experiments. Dead/unhealthy cells were excluded from analysis. The cells or images for analysis were randomly chosen. No specific randomization method was applied. The statistical parameters, including n, SEM and SD, are reported in the Figures and corresponding Figure Legends . Statistical analysis was performed in Microsoft Excel, Prism (GraphPad) and ImageJ. Statistical significance was calculated by one-way ANOVA analysis. A P value < 0.05 was considered significant. For comparison of the percentage of LDs in contact with the ER, the Chi-square test was used to test significance. No statistical methods were used to predetermine the sample size, or to determine whether the data met the assumptions of the statistical approaches used.
